# Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis

> **NCT01525134** · NA · UNKNOWN · sponsor: **Tuberculosis Clinical Diagnostics Research Consortium** · enrollment: 504 (actual)

## Conditions studied

- Tuberculosis
- Tuberculosis, Pulmonary
- Tuberculosis, Miliary

## Interventions

- **DEVICE:** Alere "Determine" lateral-flow urine lipoarabinomannan assay
- **DEVICE:** Alere "Clearview" ELISA urine LAM assay

## Key facts

- **NCT ID:** NCT01525134
- **Lead sponsor:** Tuberculosis Clinical Diagnostics Research Consortium
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-04
- **Target enrollment:** 504 (ACTUAL)
- **Last updated:** 2012-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01525134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01525134, "Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01525134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*